Cargando…

Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice

BACKGROUND: The immunogenic nature of metastatic colorectal cancer (CRC) with high microsatellite instability (MSI-H) underlies their responsiveness to immune checkpoint blockade (ICB). However, resistance to ICB is commonly observed, and is associated with the presence of peritoneal-metastases and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Küçükköse, Emre, Heesters, Balthasar A, Villaudy, Julien, Verheem, André, Cercel, Madalina, van Hal, Susan, Boj, Sylvia F, Borel Rinkes, Inne H M, Punt, Cornelis J A, Roodhart, Jeanine M L, Laoukili, Jamila, Koopman, Miriam, Spits, Hergen, Kranenburg, Onno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Clinical/Translational Cancer Immunotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772695/ https://www.ncbi.nlm.nih.gov/pubmed/36543378 http://dx.doi.org/10.1136/jitc-2022-005345

Ejemplares similares

Mismatch Repair Status in Patient-Derived Colorectal Cancer Organoids Does Not Affect Intrinsic Tumor Cell Sensitivity to Systemic Therapy
por: Küçükköse, Emre, et al.
Publicado: (2021)

KIT promotes tumor stroma formation and counteracts tumor-suppressive TGFβ signaling in colorectal cancer
por: Küçükköse, Emre, et al.
Publicado: (2022)

Loss of Neuropilin-2 in Murine Mesenchymal-like Colon Cancer Organoids Causes Mesenchymal-to-Epithelial Transition and an Acquired Dependency on Insulin-Receptor Signaling and Autophagy
por: Poghosyan, Susanna, et al.
Publicado: (2022)

CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage
por: Raats, Danielle A, et al.
Publicado: (2017)

Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures
por: van der Waals, Lizet M., et al.
Publicado: (2019)

Detection of Experimental Colorectal Peritoneal Metastases by a Novel PDGFRβ-Targeting Nanobody
por: Strating, Esther, et al.
Publicado: (2022)

Liver lymphatic drainage patterns follow segmental anatomy in a murine model
por: Frenkel, Nicola C., et al.
Publicado: (2020)

Tissue clearing and immunostaining to visualize the spatial organization of vasculature and tumor cells in mouse liver
por: Frenkel, Nicola, et al.
Publicado: (2023)

Modeling human lung infections in mice
por: Spits, Hergen, et al.
Publicado: (2019)

Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases
por: Wensink, G E, et al.
Publicado: (2023)

Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
por: Wensink, G. Emerens, et al.
Publicado: (2021)

ALDH1A1 expression is associated with poor differentiation, ‘right-sidedness’ and poor survival in human colorectal cancer
por: van der Waals, Lizet M., et al.
Publicado: (2018)

Downregulation of DNA repair proteins and increased DNA damage in hypoxic colon cancer cells is a therapeutically exploitable vulnerability
por: Jongen, Jennifer M. J., et al.
Publicado: (2017)

Paired image- and FACS-based toxicity assays for high content screening of spheroid-type tumor cell cultures
por: Trumpi, Kari, et al.
Publicado: (2015)

Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
por: Strating, Esther, et al.
Publicado: (2023)

Identification of human cytotoxic ILC3s
por: Krabbendam, Lisette, et al.
Publicado: (2021)

External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort
por: Bolhuis, Karen, et al.
Publicado: (2022)

Characterization of human FDCs reveals regulation of T cells and antigen presentation to B cells
por: Heesters, Balthasar A., et al.
Publicado: (2021)

Differential Notch and TGFβ Signaling in Primary Colorectal Tumors and Their Corresponding Metastases
por: Veenendaal, Liesbeth M., et al.
Publicado: (2008)

Mode of progression after radioembolization in patients with colorectal cancer liver metastases
por: van Roekel, Caren, et al.
Publicado: (2020)

Distinct and overlapping functions of glutathione peroxidases 1 and 2 in limiting NF-κB-driven inflammation through redox-active mechanisms
por: Koeberle, Solveigh C., et al.
Publicado: (2019)

Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition
por: van Houdt, Winan J., et al.
Publicado: (2010)

Invited Commentary: Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
por: Borel Rinkes, Inne H. M.
Publicado: (2022)

Liver lymphatic drainage patterns follow segmental anatomy
por: van den Bent, Lotte, et al.
Publicado: (2022)

Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study
por: Peters, Niek A., et al.
Publicado: (2022)

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity
por: Laoukili, Jamila, et al.
Publicado: (2022)

IMMU-07. Interim analysis of the HIT-HGG Rez Immunvac study - Dendritic cell vaccination with partial T(reg) depletion and double checkpoint blockade in children with relapsed high-grade gliomas.
por: Eyrich, Matthias, et al.
Publicado: (2022)

IMMU-13. Dual CTLA4/ PD-1 blockade improves survival for replication-repair deficient high-grade gliomas failing single agent PD-1 inhibition: An IRRDC study
por: Das, Anirban, et al.
Publicado: (2022)

Adequate symptom relief justifies hepatic resection for benign disease
por: Fioole, Bram, et al.
Publicado: (2005)

Response to Letter to the Editor on Robotic Distal Pancreatectomy, a Novel Standard of Care? Benchmark Values for Surgical Outcomes From 16 International Expert Centers
por: Müller, Philip C., et al.
Publicado: (2023)

ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer
por: Trumpi, K., et al.
Publicado: (2015)

Correction: KLRG1 and NKp46 discriminate subpopulations of human CD117(+)CRTH2(−) ILCs biased toward ILC2 or ILC3
por: Nagasawa, Maho, et al.
Publicado: (2019)

KLRG1 and NKp46 discriminate subpopulations of human CD117(+)CRTH2(−) ILCs biased toward ILC2 or ILC3
por: Nagasawa, Maho, et al.
Publicado: (2019)

Heterogeneity of type 2 innate lymphoid cells
por: Spits, Hergen, et al.
Publicado: (2022)

An (89)Zr-HDL PET Tracer Monitors Response to a CSF1R Inhibitor
por: Mason, Christian A., et al.
Publicado: (2020)

IMMU-03. UPDATES ON BRAINCHILD-01, -02, AND -03: PHASE 1 LOCOREGIONAL CAR T CELL TRIALS TARGETING HER2, EGFR, AND B7-H3 FOR CHILDREN WITH RECURRENT CNS TUMORS AND DIPG
por: Vitanza, Nicholas, et al.
Publicado: (2020)

IMMU-10. INTERIM ANALYSIS OF THE HIT-HGG REZ IMMUNVAC STUDY - DENDRITIC CELL VACCINATION WITH PARTIAL TREG DEPLETION IN CHILDREN, ADOLESCENTS, AND ADULTS WITH RELAPSED HIGH-GRADE GLIOMAS
por: Eyrich, Matthias, et al.
Publicado: (2020)

IMMU-19. HDAC INHIBITORS SENSITIZE MYC-AMPLIFIED MEDULLOBLASTOMA TO IMMUNOTHERAPY BY ACTIVATING THE NF-kB PATHWAYS
por: Marquardt, Viktoria, et al.
Publicado: (2020)

IMMU-05. B7-H3-SPECIFIC CAR T CELLS HAVE POTENT ANTI-TUMOR ACTIVITY IN THE GL261 IMMUNE-COMPETENT MURINE BRAIN TUMOR MODEL
por: Haydar, Dalia, et al.
Publicado: (2020)

IMMU-23. A NOVEL MASS CYTOMETRY-BASED MULTI-PARAMETER CHARACTERIZATION OF NEOANTIGEN-REACTIVE CD8+ T-CELLS IN PATIENTS PARTICIPATING IN PNOC007 H3.3K27M PEPTIDE VACCINE CLINICAL TRIAL
por: Taitt, Jared, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ngrdlleiufiqn44evd373nhctr